Literature DB >> 18991600

Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus.

Asli F Ceylan-Isik1, Rochelle M Fliethman, Loren E Wold, Jun Ren.   

Abstract

Cardiovascular diseases, the number one causes of death worldwide, are responsible for the majority of the increased morbidity and mortality seen in patients with diabetes mellitus. Useful therapies for diabetes include lifestyle modification and drugs to lower conventional cardiovascular risk factors, such as metformin, thiazolindinedione, sulfonylureas and evidence-based drugs. These hypoglycemic or antihyperglycemic agents are widely used either for monotherapy or in combination to improve glycemic control and to slow disease progression associated with a decline in pancreatic function in diabetic patients. In addition, a large body of clinical evidence has suggested that the appropriate use of traditional Chinese medicines with modern Western medicinal, or mainstream antidiabetic drugs, can prevent or ameliorate the development of diabetic complications. The traditional Chinese medicine diagnostics are based on "zheng" or "symptom", a system emphasizing the overall function of the human body. Since diabetes is a rather complicated metabolic disorder involving multi-organ damage, a majority of diabetic patients may be subject to multi-pharmacy to combat symptoms resulting from diabetes. Many diabetic patients choose alternative therapeutic approaches such as herbal or traditional Chinese medicine along with the mainstream anti-diabetic drugs, thus making alternative therapy for diabetes a popular remedy. In this review, we will briefly summarize the application of herbal or traditional Chinese medicinal therapy for diabetes with an emphasis on diabetic cardiovascular complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991600     DOI: 10.2174/157339908786241142

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  37 in total

Review 1.  Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.

Authors:  Min K Song; Basil D Roufogalis; Tom H W Huang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

2.  Exotic Fruits as Therapeutic Complements for Diabetes, Obesity and Metabolic Syndrome.

Authors:  Samir Devalaraja; Shalini Jain; Hariom Yadav
Journal:  Food Res Int       Date:  2011-08-01       Impact factor: 6.475

3.  Hypoglycemic Activity of Fumaria parviflora in Streptozotocin-Induced Diabetic Rats.

Authors:  Fatemeh Fathiazad; Sanaz Hamedeyazdan; Mohamad Karim Khosropanah; Arash Khaki
Journal:  Adv Pharm Bull       Date:  2013-02-07

4.  Focus group study assessing self-management skills of Chinese Americans with type 2 diabetes mellitus.

Authors:  Yue Wang; Les Chuang; William B Bateman
Journal:  J Immigr Minor Health       Date:  2012-10

5.  Dan-Shen-Yin protects the heart against inflammation and oxidative stress induced by acute ischemic myocardial injury in rats.

Authors:  Kui-Po Yan; Yong Guo; Zhihua Xing; Xi Huang; Shengping Dai; Min Duan; Xinhua Sun; Wei Huang; Weijun Peng
Journal:  Exp Ther Med       Date:  2011-12-05       Impact factor: 2.447

Review 6.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

Review 7.  Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases.

Authors:  Jun Ren; Yaguang Bi; James R Sowers; Claudio Hetz; Yingmei Zhang
Journal:  Nat Rev Cardiol       Date:  2021-02-22       Impact factor: 32.419

8.  Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.

Authors:  Jingxue Ye; Ruiying Wang; Min Wang; Jianhua Fu; Qiong Zhang; Guibo Sun; Xiaobo Sun
Journal:  Oxid Med Cell Longev       Date:  2021-05-21       Impact factor: 6.543

9.  Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism.

Authors:  Zhanhong Cao; Jianheng Pan; Xin Sui; Chunqiu Fang; Na Li; Xiaowei Huang; Xiaobo Qu; Dong Han
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-18       Impact factor: 2.629

10.  Evaluation of Effects of Chinese Prescription Kangen-karyu on Diabetes-Induced Alterations such as Oxidative Stress and Apoptosis in the Liver of Type 2 Diabetic db/db Mice.

Authors:  Chan Hum Park; Jeong Sook Noh; Takuya Okamoto; Jong Cheol Park; Takako Yokozawa
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.